Dynavax Technologies Corporation (DVAX) stock prices updated...

Dynavax Technologies Corporation stock price

Dynavax Technologies Corporation latest news:

  • 11/12/2017 10:52:16

    Third time's the charm: Dynavax shares rocket 18% on hepatitis B vaccine approval

    Marking a positive end to the company's prolonged roller-coaster ride, including major layoffs earlier this year. Dynavax Technologies Corp. (DVAX) shares surged 18% in premarket trade Friday after the company said its hepatitis B vaccine was approved by the Food and Drug Administration. The vaccine, Hepislav-B, is the first new hepatitis B vaccine in the U.S. in decades and consists of just two doses over a month, compared with current hepatitis B vaccines' three doses over six months.

  • 11/09/2017 15:13:23

    BRIEF-Dynavax says FDA approves Heplisav-B for Hepatitis B prevention in adults

    Dynavax Technologies Corp(DVAX). * Dynavax(DVAX) announces FDA approval of Heplisav-B for prevention of Hepatitis B in adults. * Dynavax Technologies Corp (DVAX) - ‍expects to commercially launch Heplisav-B in United States in Q1 of 2018​ Source text for Eikon: Further company coverage:

  • More trends:

    E*TRADE Financial CorporationETFC | Eagle Bancorp Montana, Inc.EBMT | Eagle Bancorp, Inc.EGBN | Eagle Bulk Shipping Inc.EGLE | Eagle Pharmaceuticals, Inc.EGRX | Eagle Rock Energy Partners, L.P.EROC | EarthLink Holdings Corp.ELNK | East West Bancorp, Inc.EWBC | Easterly Acquisition Corp.EACQU | Eastern Company (The)EML |